Adam F Steinlauf - Mount Sinai School of Medicine - Associate Professor

Adam F Steinlauf

Mount Sinai School of Medicine

Associate Professor

New York, New York | United States

Additional Specialties: Inflammatory Bowel Disease

Adam F Steinlauf - Mount Sinai School of Medicine - Associate Professor

Adam F Steinlauf

Introduction

Primary Affiliation: Mount Sinai School of Medicine - New York, New York , United States

Additional Specialties:

Research Interests:

Metrics

Number of Publications

12

Publications

Number of Profile Views

68

Profile Views

Number of Article Reads

113

Reads

Number of PubMed Central Citations

54

PubMed Central Citations

Top co-authors

Daniel H Present
Daniel H Present

Mount Sinai School of Medicine

2
James F Marion
James F Marion

Mount Sinai School of Medicine

2
Noam Harpaz
Noam Harpaz

Mount Sinai School of Medicine

1
Yuriy Israel
Yuriy Israel

New York Medical College

1
Mark Chapman
Mark Chapman

University of Georgia

1
Jerome D Waye
Jerome D Waye

Mount Sinai Hospital

1
Steven Itzkowitz
Steven Itzkowitz

Mount Sinai School of Medicine

1
Lloyd Mayer
Lloyd Mayer

Mount Sinai School of Medicine

1
James Aisenberg
James Aisenberg

Mount Sinai School of Medicine

1

Publications

12Publications

113Reads

54PubMed Central Citations

Perianal Fistulas in Patients With Crohn's Disease, Part 2: Surgical, Endoscopic, and Future Therapies.

Gastroenterol Hepatol (N Y) 2018 Sep;14(9):521-528

Dr Gold is an internal medicine resident in the Department of Medicine at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York.

View Article
September 2018
14 Reads

Perianal Fistulas in Patients With Crohn's Disease, Part 1: Current Medical Management.

Gastroenterol Hepatol (N Y) 2018 Aug;14(8):470-481

Dr Gold is an internal medicine resident in the Department of Medicine at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York.

View Article
August 2018
4 Reads
1 PubMed Central Citation(source)

Delays in Initiating Post-operative Prophylactic Biologic Therapy Are Common Among Crohn's Disease Patients.

Dig Dis Sci 2018 Jun 7. Epub 2018 Jun 7.

Division of Gastroenterology and Hepatology, New York Presbyterian Weill Cornell Medical Center, New York, NY, 10021, USA.

View Article
June 2018
7 Reads
2.55 Impact Factor

Risk Stratification for Prevention of Recurrence of Postoperative Crohn's Disease.

Gastroenterol Hepatol (N Y) 2017 Nov;13(11):651-658

Dr Cohen-Mekelburg and Dr Schneider are gastroenterology fellows, Dr Gold is an internal medicine resident, Dr Scherl is a clinical professor and attending physician, and Dr Steinlauf is an assistant professor and attending physician at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York.

View Article
November 2017
11 Reads

Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study.

Inflamm Bowel Dis 2017 10;23(10):1882-1889

*Department of Medicine, New York Presbyterian Weill Cornell Medical College, New York, New York; †Department of Gastroenterology and Hepatology, New York Presbyterian Weill Cornell Medical College, New York, New York; ‡Weill Cornell Medical College, New York, New York; and §Department of Medicine, New York University, New York, New York.

View Article
October 2017
27 Reads
1 PubMed Central Citation(source)
4.46 Impact Factor

Advances in the Diagnosis and Management of Colonic Dysplasia in Patients With Inflammatory Bowel Disease.

Gastroenterol Hepatol (N Y) 2017 Jun;13(6):357-362

Dr Cohen-Mekelburg and Dr Schneider are gastroenterology fellows, Dr Gold is an internal medicine resident, Dr Scherl is a clinical professor and attending physician, and Dr Steinlauf is an assistant professor and attending physician at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York.

View Article
June 2017
9 Reads

Adherence to Postoperative Endoscopic Surveillance in Patients with Crohn's Disease.

Inflamm Bowel Dis 2017 04;23(4):E18

NewYork Presbyterian Weill Cornell Medical Center, New York, New York.

View Article
April 2017
6 Reads
4.46 Impact Factor

The Cost-Effectiveness of Vedolizumab for Inflammatory Bowel Disease: A Review of the Current Literature.

Gastroenterol Hepatol (N Y) 2016 Oct;12(10):617-621

Dr Schneider, Dr Saumoy, and Dr Cohen-Mekelburg are clinical fellows; Dr Steinlauf is an assistant professor of medicine; and Dr Scherl is a professor of clinical medicine in the Division of Gastroenterology and Hepatology at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York.

View Article
October 2016
9 Reads
1 PubMed Central Citation(source)

Bone, inflammation, and inflammatory bowel disease.

Curr Osteoporos Rep 2011 Dec;9(4):251-7

Department of Gastroenterology, Maimonides Medical Center, Brooklyn, NY 11201, USA.

View Article
December 2011
3 Reads
6 PubMed Central Citations(source)

Medical management of the pregnant patient with inflammatory bowel disease.

Gastroenterol Clin North Am 2004 Jun;33(2):361-85, xi

Mount Sinai School of Medicine, Mount Sinai Hospital, 12 East 86th Street, New York, NY 10028, USA.

View Article
June 2004
4 Reads
1 PubMed Central Citation(source)
2.82 Impact Factor

Top co-authors

Daniel H Present
Daniel H Present

Mount Sinai School of Medicine

2
James F Marion
James F Marion

Mount Sinai School of Medicine

2
Noam Harpaz
Noam Harpaz

Mount Sinai School of Medicine

1
Yuriy Israel
Yuriy Israel

New York Medical College

1
Mark Chapman
Mark Chapman

University of Georgia

1
Jerome D Waye
Jerome D Waye

Mount Sinai Hospital

1
Steven Itzkowitz
Steven Itzkowitz

Mount Sinai School of Medicine

1
Lloyd Mayer
Lloyd Mayer

Mount Sinai School of Medicine

1
James Aisenberg
James Aisenberg

Mount Sinai School of Medicine

1